Component
Human mechanistic target of rapamycin kinase / MTOR
Human MTOR kinase protein. Distinct from the mTORC1 complex; linked claims specify which signaling measurement was performed.
15 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What acts on it
Orthosilicic acid increased PI3K, phosphorylated Akt and mTOR together with osteogenic markers.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Human osteoblast-like cell study.
- limitations
- No direct binding target or dietary requirement is established.
- nutrient_topic
- Silica collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Silica and soluble silicon
- plain_language
- A growth-related pathway accompanied matrix production.
- primary_references
- Orthosilicic Acid Accelerates Bone Formation in Human Osteoblast-Like Cells Through the PI3K-Akt-mTOR Pathway. · 2019 · https://pubmed.ncbi.nlm.nih.gov/30421162/ · DOI 10.1007/s12011-018-1574-9
Silica: soluble silicon, cellular transport and particle-specific mechanisms (2026-09-19) · lines 168–174
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human osteoblast-like cell study. · source_derived_draft · unverified_draft
## silica-pi3k-mtor A growth-related pathway accompanied matrix production. Orthosilicic acid increased PI3K, phosphorylated Akt and mTOR together with osteogenic markers. Model: Human osteoblast-like cell study. Limitations: No direct binding target or dietary requirement is established. Evidence access: Primary abstract Orthosilicic Acid Accelerates Bone Formation in Human Osteoblast-Like Cells Through the PI3K-Akt-mTOR Pathway. · 2019 · https://pubmed.ncbi.nlm.nih.gov/30421162/ · DOI 10.1007/s12011-018-1574-9
Complete structured claim and evidenceIFN-gamma/IDO-driven tryptophan depletion reduced S6K phosphorylation in human HeLa cells; tryptophan repletion restored the mTOR readout.
Experimental context and source evidence
- availability_state
- nutrient_deficiency Imported condition classification; unverified.
- evidence_access
- Primary full text, Figure 2
- experimental_model
- Human HeLa cells, depleted media and amino-acid add-back.
- limitations
- S6K phosphorylation is a pathway readout, not direct tryptophan binding to MTOR.
- nutrient_topic
- Tryptophan collection; molecular form, preparation, species, exposure and manipulation remain explicit. · L-Tryptophan
- plain_language
- Local depletion reduced a growth signal as well as changing metabolite supply.
- primary_references
- IDO inhibits a tryptophan sufficiency signal that stimulates mTOR: A novel IDO effector pathway targeted by D-1-methyl-tryptophan. · 2012 · https://pubmed.ncbi.nlm.nih.gov/23264892/ · DOI 10.4161/onci.21716
- trigger_kind
- nutrient_deficiency Imported condition classification; unverified.
Tryptophan: transport, protein synthesis, neuroactive metabolites, NAD and microbial pathways (2026-09-19) · lines 402–408
AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Human HeLa cells, depleted media and amino-acid add-back. · source_derived_draft · unverified_draft
## tryptophan-trp-mtor Local depletion reduced a growth signal as well as changing metabolite supply. IFN-gamma/IDO-driven tryptophan depletion reduced S6K phosphorylation in human HeLa cells; tryptophan repletion restored the mTOR readout. Model: Human HeLa cells, depleted media and amino-acid add-back. Limitations: S6K phosphorylation is a pathway readout, not direct tryptophan binding to MTOR. Evidence access: Primary full text, Figure 2 IDO inhibits a tryptophan sufficiency signal that stimulates mTOR: A novel IDO effector pathway targeted by D-1-methyl-tryptophan. · 2012 · https://pubmed.ncbi.nlm.nih.gov/23264892/ · DOI 10.4161/onci.21716
Complete structured claim and evidenceCell-free competition and activity assays supported fisetin binding and inhibition of mTOR in the human melanoma study.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Human melanoma models plus cell-free kinase assays.
- limitations
- Docking was supplemented by biochemical assays; clinical target engagement remains unproven.
- nutrient_topic
- Fisetin collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Fisetin
- plain_language
- A binding assay supports a more direct target relationship.
- primary_references
- Fisetin inhibits human melanoma cell growth through direct binding to p70S6K and mTOR: findings from 3-D melanoma skin equivalents and computational modeling. · 2014 · https://pubmed.ncbi.nlm.nih.gov/24675012/ · DOI 10.1016/j.bcp.2014.03.007
Fisetin: metabolism, cell-state responses and cross-nutrient mechanisms (2026-09-19) · lines 272–278
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human melanoma models plus cell-free kinase assays. · source_derived_draft · unverified_draft
## fisetin-mtor-binding A binding assay supports a more direct target relationship. Cell-free competition and activity assays supported fisetin binding and inhibition of mTOR in the human melanoma study. Model: Human melanoma models plus cell-free kinase assays. Limitations: Docking was supplemented by biochemical assays; clinical target engagement remains unproven. Evidence access: Primary abstract Fisetin inhibits human melanoma cell growth through direct binding to p70S6K and mTOR: findings from 3-D melanoma skin equivalents and computational modeling. · 2014 · https://pubmed.ncbi.nlm.nih.gov/24675012/ · DOI 10.1016/j.bcp.2014.03.007
Complete structured claim and evidenceEGCG showed ATP-competitive inhibition with Ki 320 nanomolar in the reported enzyme assay.
Experimental context and source evidence
- experimental_model
- Biochemical kinase assays plus MDA-MB-231 and A549 cell experiments.
- limitations
- PI3K isoform is not assigned from abstract; docking is a model, not a solved ligand structure.
- nutrient_topic
- EGCG collection; comparator and shared-pathway records retain their actual intervention. · Epigallocatechin-3-gallate (EGCG)
- plain_language
- EGCG competed with the enzyme’s energy substrate.
- primary_references
- Epigallocatechin gallate (EGCG), a major component of green tea, is a dual phosphoinositide-3-kinase/mTOR inhibitor. · 2011 · https://pubmed.ncbi.nlm.nih.gov/21300025/ · DOI 10.1016/j.bbrc.2011.02.010
EGCG: receptor signaling, metabolism, nutrient interactions and discovery questions (2026-09-18) · lines 220–226
AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Biochemical kinase assays plus MDA-MB-231 and A549 cell experiments. · source_derived_draft · unverified_draft
## egcg-mtor EGCG competed with the enzyme’s energy substrate. EGCG showed ATP-competitive inhibition with Ki 320 nanomolar in the reported enzyme assay. Model: Biochemical kinase assays plus MDA-MB-231 and A549 cell experiments. Limitations: PI3K isoform is not assigned from abstract; docking is a model, not a solved ligand structure. Evidence access: primary abstract. Epigallocatechin gallate (EGCG), a major component of green tea, is a dual phosphoinositide-3-kinase/mTOR inhibitor. · 2011 · https://pubmed.ncbi.nlm.nih.gov/21300025/ · DOI 10.1016/j.bbrc.2011.02.010
Complete structured claim and evidence
Where it participates (unsigned role)
Biotin-deficient human CD4 T cells secreted more IFN-gamma after anti-CD3/CD28 stimulation.
Experimental context and source evidence
- availability_state
- nutrient_deficiency Imported condition classification; unverified.
- evidence_span
- {"source_cache": "artifacts/biotin-research/29531163.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "64511b88fc7991ad24a1d7c122f5147b1bd99522532fa61752b439f39d363b6f", "start_char": 0, "end_char": 1720, "text_sha256": "64511b88fc7991ad24a1d7c122f5147b1bd99522532fa61752b439f39d363b6f"}
- experimental_model
- Anti-CD3/CD28-stimulated human CD4 T cells in biotin-deficient culture; separate mouse validation
- exposure
- Defined biotin deficiency and signaling experiments
- limitations
- Cell-culture inflammation does not show that extra biotin treats autoimmune disease in replete people.
- nutrient_topic
- Biotin research collection; topical membership is not evidence of a direct dietary effect. · Biotin
- organism
- Homo sapiens
- plain_language
- Activated T cells released more of one inflammatory signal.
- primary_references
- [b7-p29531163] Biotin Deficiency Induces Th1- and Th17-Mediated Proinflammatory Responses in Human CD4+ T Lymphocytes via Activation of the mTOR Signaling Pathway. (2018). https://pubmed.ncbi.nlm.nih.gov/29531163/ DOI: 10.4049/jimmunol.1701200
- tissue_or_cell_type
- Activated CD4 T cells
- trigger_kind
- nutrient_deficiency Imported condition classification; unverified.
Biotin: carboxylases, recycling, deficiency and nutrient interactions (2026-09-17) · lines 1053–1064
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Anti-CD3/CD28-stimulated human CD4 T cells in biotin-deficient culture; separate mouse validation · source_derived_draft · unverified_draft
### b7-immune-ifng Biotin-deficient human CD4 T cells secreted more IFN-gamma after anti-CD3/CD28 stimulation. Condition category: nutrient_deficiency nutrient_topic: Biotin research collection; topical membership is not evidence of a direct dietary effect. plain_language: Activated T cells released more of one inflammatory signal. organism: Homo sapiens tissue_or_cell_type: Activated CD4 T cells experimental_model: Anti-CD3/CD28-stimulated human CD4 T cells in biotin-deficient culture; separate mouse validation limitations: Cell-culture inflammation does not show that extra biotin treats autoimmune disease in replete people. exposure: Defined biotin deficiency and signaling experiments evidence_span: {"source_cache": "artifacts/biotin-research/29531163.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "64511b88fc7991ad24a1d7c122f5147b1bd99522532fa61752b439f39d363b6f", "start_char": 0, "end_char": 1720, "text_sha256": "64511b88fc7991ad24a1d7c122f5147b1bd99522532fa61752b439f39d363b6f"} [b7-p29531163] Biotin Deficiency Induces Th1- and Th17-Mediated Proinflammatory Responses in Human CD4+ T Lymphocytes via Activation of the mTOR Signaling Pathway. (2018). https://pubmed.ncbi.nlm.nih.gov/29531163/ DOI: 10.4049/jimmunol.1701200
Complete structured claim and evidenceBiotin-deficient human CD4 T cells secreted more IL-17 after anti-CD3/CD28 stimulation.
Experimental context and source evidence
- availability_state
- nutrient_deficiency Imported condition classification; unverified.
- evidence_span
- {"source_cache": "artifacts/biotin-research/29531163.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "64511b88fc7991ad24a1d7c122f5147b1bd99522532fa61752b439f39d363b6f", "start_char": 0, "end_char": 1720, "text_sha256": "64511b88fc7991ad24a1d7c122f5147b1bd99522532fa61752b439f39d363b6f"}
- experimental_model
- Anti-CD3/CD28-stimulated human CD4 T cells in biotin-deficient culture; separate mouse validation
- exposure
- Defined biotin deficiency and signaling experiments
- limitations
- Cell-culture inflammation does not show that extra biotin treats autoimmune disease in replete people.
- nutrient_topic
- Biotin research collection; topical membership is not evidence of a direct dietary effect. · Biotin
- organism
- Homo sapiens
- plain_language
- The response also shifted toward an IL-17-associated inflammatory pattern.
- primary_references
- [b7-p29531163] Biotin Deficiency Induces Th1- and Th17-Mediated Proinflammatory Responses in Human CD4+ T Lymphocytes via Activation of the mTOR Signaling Pathway. (2018). https://pubmed.ncbi.nlm.nih.gov/29531163/ DOI: 10.4049/jimmunol.1701200
- tissue_or_cell_type
- Activated CD4 T cells
- trigger_kind
- nutrient_deficiency Imported condition classification; unverified.
Biotin: carboxylases, recycling, deficiency and nutrient interactions (2026-09-17) · lines 1079–1090
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Anti-CD3/CD28-stimulated human CD4 T cells in biotin-deficient culture; separate mouse validation · source_derived_draft · unverified_draft
### b7-immune-il17 Biotin-deficient human CD4 T cells secreted more IL-17 after anti-CD3/CD28 stimulation. Condition category: nutrient_deficiency nutrient_topic: Biotin research collection; topical membership is not evidence of a direct dietary effect. plain_language: The response also shifted toward an IL-17-associated inflammatory pattern. organism: Homo sapiens tissue_or_cell_type: Activated CD4 T cells experimental_model: Anti-CD3/CD28-stimulated human CD4 T cells in biotin-deficient culture; separate mouse validation limitations: Cell-culture inflammation does not show that extra biotin treats autoimmune disease in replete people. exposure: Defined biotin deficiency and signaling experiments evidence_span: {"source_cache": "artifacts/biotin-research/29531163.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "64511b88fc7991ad24a1d7c122f5147b1bd99522532fa61752b439f39d363b6f", "start_char": 0, "end_char": 1720, "text_sha256": "64511b88fc7991ad24a1d7c122f5147b1bd99522532fa61752b439f39d363b6f"} [b7-p29531163] Biotin Deficiency Induces Th1- and Th17-Mediated Proinflammatory Responses in Human CD4+ T Lymphocytes via Activation of the mTOR Signaling Pathway. (2018). https://pubmed.ncbi.nlm.nih.gov/29531163/ DOI: 10.4049/jimmunol.1701200
Complete structured claim and evidenceThe study linked the heightened inflammatory response of biotin-deficient human CD4 T cells to enhanced mTOR-pathway activation.
Experimental context and source evidence
- availability_state
- nutrient_deficiency Imported condition classification; unverified.
- evidence_span
- {"source_cache": "artifacts/biotin-research/29531163.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "64511b88fc7991ad24a1d7c122f5147b1bd99522532fa61752b439f39d363b6f", "start_char": 0, "end_char": 1720, "text_sha256": "64511b88fc7991ad24a1d7c122f5147b1bd99522532fa61752b439f39d363b6f"}
- experimental_model
- Anti-CD3/CD28-stimulated human CD4 T cells in biotin-deficient culture; separate mouse validation
- exposure
- Defined biotin deficiency and signaling experiments
- limitations
- Cell-culture inflammation does not show that extra biotin treats autoimmune disease in replete people.
- nutrient_topic
- Biotin research collection; topical membership is not evidence of a direct dietary effect. · Biotin
- organism
- Homo sapiens
- plain_language
- Changes in metabolic signaling accompanied the altered immune response.
- primary_references
- [b7-p29531163] Biotin Deficiency Induces Th1- and Th17-Mediated Proinflammatory Responses in Human CD4+ T Lymphocytes via Activation of the mTOR Signaling Pathway. (2018). https://pubmed.ncbi.nlm.nih.gov/29531163/ DOI: 10.4049/jimmunol.1701200
- tissue_or_cell_type
- Activated CD4 T cells
- trigger_kind
- nutrient_deficiency Imported condition classification; unverified.
Biotin: carboxylases, recycling, deficiency and nutrient interactions (2026-09-17) · lines 1092–1103
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Anti-CD3/CD28-stimulated human CD4 T cells in biotin-deficient culture; separate mouse validation · source_derived_draft · unverified_draft
### b7-immune-mtor The study linked the heightened inflammatory response of biotin-deficient human CD4 T cells to enhanced mTOR-pathway activation. Condition category: nutrient_deficiency nutrient_topic: Biotin research collection; topical membership is not evidence of a direct dietary effect. plain_language: Changes in metabolic signaling accompanied the altered immune response. organism: Homo sapiens tissue_or_cell_type: Activated CD4 T cells experimental_model: Anti-CD3/CD28-stimulated human CD4 T cells in biotin-deficient culture; separate mouse validation limitations: Cell-culture inflammation does not show that extra biotin treats autoimmune disease in replete people. exposure: Defined biotin deficiency and signaling experiments evidence_span: {"source_cache": "artifacts/biotin-research/29531163.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "64511b88fc7991ad24a1d7c122f5147b1bd99522532fa61752b439f39d363b6f", "start_char": 0, "end_char": 1720, "text_sha256": "64511b88fc7991ad24a1d7c122f5147b1bd99522532fa61752b439f39d363b6f"} [b7-p29531163] Biotin Deficiency Induces Th1- and Th17-Mediated Proinflammatory Responses in Human CD4+ T Lymphocytes via Activation of the mTOR Signaling Pathway. (2018). https://pubmed.ncbi.nlm.nih.gov/29531163/ DOI: 10.4049/jimmunol.1701200
Complete structured claim and evidenceBiotin-deficient human CD4 T cells secreted more TNF after anti-CD3/CD28 stimulation.
Experimental context and source evidence
- availability_state
- nutrient_deficiency Imported condition classification; unverified.
- evidence_span
- {"source_cache": "artifacts/biotin-research/29531163.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "64511b88fc7991ad24a1d7c122f5147b1bd99522532fa61752b439f39d363b6f", "start_char": 0, "end_char": 1720, "text_sha256": "64511b88fc7991ad24a1d7c122f5147b1bd99522532fa61752b439f39d363b6f"}
- experimental_model
- Anti-CD3/CD28-stimulated human CD4 T cells in biotin-deficient culture; separate mouse validation
- exposure
- Defined biotin deficiency and signaling experiments
- limitations
- Cell-culture inflammation does not show that extra biotin treats autoimmune disease in replete people.
- nutrient_topic
- Biotin research collection; topical membership is not evidence of a direct dietary effect. · Biotin
- organism
- Homo sapiens
- plain_language
- A second inflammatory signal also increased.
- primary_references
- [b7-p29531163] Biotin Deficiency Induces Th1- and Th17-Mediated Proinflammatory Responses in Human CD4+ T Lymphocytes via Activation of the mTOR Signaling Pathway. (2018). https://pubmed.ncbi.nlm.nih.gov/29531163/ DOI: 10.4049/jimmunol.1701200
- tissue_or_cell_type
- Activated CD4 T cells
- trigger_kind
- nutrient_deficiency Imported condition classification; unverified.
Biotin: carboxylases, recycling, deficiency and nutrient interactions (2026-09-17) · lines 1066–1077
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Anti-CD3/CD28-stimulated human CD4 T cells in biotin-deficient culture; separate mouse validation · source_derived_draft · unverified_draft
### b7-immune-tnf Biotin-deficient human CD4 T cells secreted more TNF after anti-CD3/CD28 stimulation. Condition category: nutrient_deficiency nutrient_topic: Biotin research collection; topical membership is not evidence of a direct dietary effect. plain_language: A second inflammatory signal also increased. organism: Homo sapiens tissue_or_cell_type: Activated CD4 T cells experimental_model: Anti-CD3/CD28-stimulated human CD4 T cells in biotin-deficient culture; separate mouse validation limitations: Cell-culture inflammation does not show that extra biotin treats autoimmune disease in replete people. exposure: Defined biotin deficiency and signaling experiments evidence_span: {"source_cache": "artifacts/biotin-research/29531163.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "64511b88fc7991ad24a1d7c122f5147b1bd99522532fa61752b439f39d363b6f", "start_char": 0, "end_char": 1720, "text_sha256": "64511b88fc7991ad24a1d7c122f5147b1bd99522532fa61752b439f39d363b6f"} [b7-p29531163] Biotin Deficiency Induces Th1- and Th17-Mediated Proinflammatory Responses in Human CD4+ T Lymphocytes via Activation of the mTOR Signaling Pathway. (2018). https://pubmed.ncbi.nlm.nih.gov/29531163/ DOI: 10.4049/jimmunol.1701200
Complete structured claim and evidenceActivation of the cholesterol synthesis pathway but not the synthesis of cholesterol itself is essential for training of myeloid cells, rather the metabolite mevalonate is the mediator of training via activation of IGF1-R and mTOR and subsequent histone modifications in inflammatory pathways, statins which block mevalonate generation prevent trained immunity induction, and monocytes of patients with hyper immunoglobulin D syndrome who are mevalonate kinase deficient and accumulate mevalonate have a constitutive trained immunity phenotype at both immunological and epigenetic levels.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/glucan-research/29328908.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "c7d8052926f6be1dad87fedf0023f60ac5441b04f9b8e180c4b1e07edc83eb03", "start_char": 0, "end_char": 1173, "text_sha256": "c7d8052926f6be1dad87fedf0023f60ac5441b04f9b8e180c4b1e07edc83eb03"}
- experimental_model
- Pharmacological and genetic dissection of the cholesterol synthesis pathway, with monocytes from patients accumulating mevalonate
- exposure
- Training of myeloid cells with statins to block mevalonate generation, and monocytes from mevalonate kinase deficient patients
- limitations
- The patient arm is a natural experiment in the opposite direction, which is what makes the mevalonate assignment convincing. The statin result is inhibition of an induced laboratory response.
- nutrient_topic
- Beta-glucan research collection; topical membership is not evidence of a direct clinical effect, and each preparation is recorded as its own entity with no family link joining any pair. · Beta-glucan
- organism
- Human
- plain_language
- It is the intermediate and not the cholesterol that does the training, and people who cannot clear that intermediate are permanently trained.
- primary_references
- [bg-p29328908] Metabolic Induction of Trained Immunity through the Mevalonate Pathway. (2018). https://pubmed.ncbi.nlm.nih.gov/29328908/ DOI: 10.1016/j.cell.2017.11.025
- tissue_or_cell_type
- Monocyte
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Pharmacological and genetic dissection of the cholesterol synthesis pathway, with monocytes from patients accumulating mevalonate · source_derived_draft · unverified_draft
### bg-mevalonate-not-cholesterol-trains Activation of the cholesterol synthesis pathway but not the synthesis of cholesterol itself is essential for training of myeloid cells, rather the metabolite mevalonate is the mediator of training via activation of IGF1-R and mTOR and subsequent histone modifications in inflammatory pathways, statins which block mevalonate generation prevent trained immunity induction, and monocytes of patients with hyper immunoglobulin D syndrome who are mevalonate kinase deficient and accumulate mevalonate have a constitutive trained immunity phenotype at both immunological and epigenetic levels. Condition category: normal nutrient_topic: Beta-glucan research collection; topical membership is not evidence of a direct clinical effect, and each preparation is recorded as its own entity with no family link joining any pair. plain_language: It is the intermediate and not the cholesterol that does the training, and people who cannot clear that intermediate are permanently trained. organism: Human tissue_or_cell_type: Monocyte experimental_model: Pharmacological and genetic dissection of the cholesterol synthesis pathway, with monocytes from patients accumulating mevalonate limitations: The patient arm is a natural experiment in the opposite direction, which is what makes the mevalonate assignment convincing. The statin result is inhibition of an induced laboratory response. exposure: Training of myeloid cells with statins to block mevalonate generation, and monocytes from mevalonate kinase deficient patients evidence_span: {"source_cache": "artifacts/glucan-research/29328908.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "c7d8052926f6be1dad87fedf0023f60ac5441b04f9b8e180c4b1e07edc83eb03", "start_char": 0, "end_char": 1173, "text_sha256": "c7d8052926f6be1dad87fedf0023f60ac5441b04f9b8e180c4b1e07edc83eb03"} [bg-p29328908] Metabolic Induction of Trained Immunity through the Mevalonate Pathway. (2018). https://pubmed.ncbi.nlm.nih.gov/29328908/ DOI: 10.1016/j.cell.2017.11.025
Complete structured claim and evidenceTrained monocytes display high glucose consumption, high lactate production and a high ratio of NAD+ to NADH, reflecting a shift in metabolism with an increase in glycolysis dependent on the activation of mammalian target of rapamycin through a dectin-1-Akt-HIF-1 alpha pathway, inhibition of Akt, mTOR or HIF-1 alpha blocked monocyte induction of trained immunity whereas the AMP-activated protein kinase activator metformin inhibited the innate immune response to fungal infection, and mice with a myeloid cell-specific defect in HIF-1 alpha were unable to mount trained immunity against bacterial sepsis.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/glucan-research/25258083.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "68c4cae9a0e4477a52864e63ecaf5ec977752b5d3246a9ba54aa22d160e41872", "start_char": 0, "end_char": 1225, "text_sha256": "68c4cae9a0e4477a52864e63ecaf5ec977752b5d3246a9ba54aa22d160e41872"}
- experimental_model
- Histone modification profiling and genome-wide transcriptome of trained human monocytes, with pathway inhibition and a myeloid conditional knockout
- exposure
- Beta-glucan training with inhibition of Akt, mTOR or HIF-1 alpha, and metformin as an AMPK activator
- limitations
- The metformin result is an experimental inhibition of an induced response, not a clinical interaction study.
- nutrient_topic
- Beta-glucan research collection; topical membership is not evidence of a direct clinical effect, and each preparation is recorded as its own entity with no family link joining any pair. · Beta-glucan
- organism
- Human cells and mouse
- plain_language
- The rewiring costs energy: block the cell from burning glucose the fast way and the training does not take.
- primary_references
- [bg-p25258083] mTOR- and HIF-1α-mediated aerobic glycolysis as metabolic basis for trained immunity. (2014). https://pubmed.ncbi.nlm.nih.gov/25258083/ DOI: 10.1126/science.1250684
- tissue_or_cell_type
- Monocyte
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Histone modification profiling and genome-wide transcriptome of trained human monocytes, with pathway inhibition and a myeloid conditional knockout · source_derived_draft · unverified_draft
### bg-training-needs-aerobic-glycolysis Trained monocytes display high glucose consumption, high lactate production and a high ratio of NAD+ to NADH, reflecting a shift in metabolism with an increase in glycolysis dependent on the activation of mammalian target of rapamycin through a dectin-1-Akt-HIF-1 alpha pathway, inhibition of Akt, mTOR or HIF-1 alpha blocked monocyte induction of trained immunity whereas the AMP-activated protein kinase activator metformin inhibited the innate immune response to fungal infection, and mice with a myeloid cell-specific defect in HIF-1 alpha were unable to mount trained immunity against bacterial sepsis. Condition category: normal nutrient_topic: Beta-glucan research collection; topical membership is not evidence of a direct clinical effect, and each preparation is recorded as its own entity with no family link joining any pair. plain_language: The rewiring costs energy: block the cell from burning glucose the fast way and the training does not take. organism: Human cells and mouse tissue_or_cell_type: Monocyte experimental_model: Histone modification profiling and genome-wide transcriptome of trained human monocytes, with pathway inhibition and a myeloid conditional knockout limitations: The metformin result is an experimental inhibition of an induced response, not a clinical interaction study. exposure: Beta-glucan training with inhibition of Akt, mTOR or HIF-1 alpha, and metformin as an AMPK activator evidence_span: {"source_cache": "artifacts/glucan-research/25258083.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "68c4cae9a0e4477a52864e63ecaf5ec977752b5d3246a9ba54aa22d160e41872", "start_char": 0, "end_char": 1225, "text_sha256": "68c4cae9a0e4477a52864e63ecaf5ec977752b5d3246a9ba54aa22d160e41872"} [bg-p25258083] mTOR- and HIF-1α-mediated aerobic glycolysis as metabolic basis for trained immunity. (2014). https://pubmed.ncbi.nlm.nih.gov/25258083/ DOI: 10.1126/science.1250684
Complete structured claim and evidenceLY294002 reduced pathway signals and osteogenic markers during orthosilicic acid treatment.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_access
- Primary abstract
- experimental_model
- Human osteoblast-like cultures.
- limitations
- LY294002 has off-target effects and is not an inhibitor specific to the entire PI3K–Akt–mTOR chain.
- nutrient_topic
- Silica collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Silica and soluble silicon
- plain_language
- The cell response was sensitive to PI3K-pathway blockade.
- primary_references
- Orthosilicic Acid Accelerates Bone Formation in Human Osteoblast-Like Cells Through the PI3K-Akt-mTOR Pathway. · 2019 · https://pubmed.ncbi.nlm.nih.gov/30421162/ · DOI 10.1007/s12011-018-1574-9
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Silica: soluble silicon, cellular transport and particle-specific mechanisms (2026-09-19) · lines 176–182
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human osteoblast-like cultures. · source_derived_draft · unverified_draft
## silica-ly294002-block The cell response was sensitive to PI3K-pathway blockade. LY294002 reduced pathway signals and osteogenic markers during orthosilicic acid treatment. Model: Human osteoblast-like cultures. Limitations: LY294002 has off-target effects and is not an inhibitor specific to the entire PI3K–Akt–mTOR chain. Evidence access: Primary abstract Orthosilicic Acid Accelerates Bone Formation in Human Osteoblast-Like Cells Through the PI3K-Akt-mTOR Pathway. · 2019 · https://pubmed.ncbi.nlm.nih.gov/30421162/ · DOI 10.1007/s12011-018-1574-9
Complete structured claim and evidenceMuscle insulin-stimulated AKT and mTOR phosphorylation and total abundance increased after NMN but not placebo.
Experimental context and source evidence
- cross_nutrient
- Insulin (stimulus)
- evidence_span
- {"source_cache": "artifacts/niacin-clinical-sources/yoshino2021.txt", "locator": "Primary full report; exact character range, zero-based and end-exclusive", "file_sha256": "e4999dc5b9d3392d8180280727c424044b35249bb24c999c3bc863cd23e6c856", "start_char": 7141, "end_char": 7815, "text_sha256": "31871685ed5bb9ceb845b035d50807218311c0fad543f690e5ab924ba9872d0d"}
- experimental_model
- Randomized double-blind trial; 25 overweight or obese postmenopausal women with prediabetes completed
- exposure
- NMN 250 mg/day for 10 weeks; 13 NMN and 12 placebo participants
- limitations
- Small selected female cohort. Tissue NAD concentration, NAD turnover and clinical outcomes differ. No lifespan or diabetes-prevention endpoint. Positive muscle findings do not establish whole-body or cross-population benefit.
- nutrient_topic
- Niacin research collection; topical membership is not evidence of a direct dietary effect. · Niacin (vitamin B3)
- organism
- Homo sapiens
- plain_language
- The muscle response was accompanied by changes in insulin-signaling proteins.
- primary_references
- [nia-clin-yoshino2021] Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. (2021). https://pubmed.ncbi.nlm.nih.gov/33888596/ DOI: 10.1126/science.abe9985
- tissue_or_cell_type
- Skeletal muscle, PBMCs, liver and adipose insulin sensitivity
Niacin: NAD metabolism, deficiency and nutrient interactions (2026-09-17) · lines 1501–1513
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Randomized double-blind trial; 25 overweight or obese postmenopausal women with prediabetes completed · source_derived_draft · unverified_draft
### nia-clin-nmn-muscle-signal Muscle insulin-stimulated AKT and mTOR phosphorylation and total abundance increased after NMN but not placebo. Condition category: normal nutrient_topic: Niacin research collection; topical membership is not evidence of a direct dietary effect. plain_language: The muscle response was accompanied by changes in insulin-signaling proteins. organism: Homo sapiens tissue_or_cell_type: Skeletal muscle, PBMCs, liver and adipose insulin sensitivity experimental_model: Randomized double-blind trial; 25 overweight or obese postmenopausal women with prediabetes completed limitations: Small selected female cohort. Tissue NAD concentration, NAD turnover and clinical outcomes differ. No lifespan or diabetes-prevention endpoint. Positive muscle findings do not establish whole-body or cross-population benefit. exposure: NMN 250 mg/day for 10 weeks; 13 NMN and 12 placebo participants cross_nutrient: Insulin (stimulus) evidence_span: {"source_cache": "artifacts/niacin-clinical-sources/yoshino2021.txt", "locator": "Primary full report; exact character range, zero-based and end-exclusive", "file_sha256": "e4999dc5b9d3392d8180280727c424044b35249bb24c999c3bc863cd23e6c856", "start_char": 7141, "end_char": 7815, "text_sha256": "31871685ed5bb9ceb845b035d50807218311c0fad543f690e5ab924ba9872d0d"} [nia-clin-yoshino2021] Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. (2021). https://pubmed.ncbi.nlm.nih.gov/33888596/ DOI: 10.1126/science.abe9985
Complete structured claim and evidencePost-exercise mTORC1 signalling measured as rps6 phosphorylation was blunted at 1 and 48 hours after training, basal FOXO1 protein content increased 1.3-fold, and training-induced increases in heat shock protein 27 were attenuated with reduced total heat shock protein 72.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/cold-research/31513450.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "f39d3b6bef4879805e7aab7b14df67921ac12765af5d4466836936039ad7a872", "start_char": 0, "end_char": 2195, "text_sha256": "f39d3b6bef4879805e7aab7b14df67921ac12765af5d4466836936039ad7a872"}
- experimental_model
- Sixteen men completing seven weeks of whole-body resistance training with immersion or passive recovery
- exposure
- 15 minutes at 10 degrees C after each session, three days a week for seven weeks
- limitations
- A second training study with molecular endpoints. It reproduces the fibre-size result but not the strength result, which is the disagreement recorded in this collection.
- nutrient_topic
- Cold water immersion research collection; topical membership is not evidence of a direct clinical effect, and a therapeutic exposure is not a dietary intake. · Cold water immersion
- organism
- Human
- plain_language
- The building signal was turned down, the breakdown marker went up, and the muscle stress proteins did not accumulate.
- primary_references
- [cold-p31513450] Cold water immersion attenuates anabolic signaling and skeletal muscle fiber hypertrophy, but not strength gain, following whole-body resistance training. (2019). https://pubmed.ncbi.nlm.nih.gov/31513450/ DOI: 10.1152/japplphysiol.00127.2019
- tissue_or_cell_type
- Skeletal muscle
Cold water immersion: cold sensing, heat production, the catecholamine axis and what repeated exposure changes (2026-09-19) · lines 845–856
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Sixteen men completing seven weeks of whole-body resistance training with immersion or passive recovery · source_derived_draft · unverified_draft
### cold-cwi-anabolic-catabolic Post-exercise mTORC1 signalling measured as rps6 phosphorylation was blunted at 1 and 48 hours after training, basal FOXO1 protein content increased 1.3-fold, and training-induced increases in heat shock protein 27 were attenuated with reduced total heat shock protein 72. Condition category: normal nutrient_topic: Cold water immersion research collection; topical membership is not evidence of a direct clinical effect, and a therapeutic exposure is not a dietary intake. plain_language: The building signal was turned down, the breakdown marker went up, and the muscle stress proteins did not accumulate. organism: Human tissue_or_cell_type: Skeletal muscle experimental_model: Sixteen men completing seven weeks of whole-body resistance training with immersion or passive recovery limitations: A second training study with molecular endpoints. It reproduces the fibre-size result but not the strength result, which is the disagreement recorded in this collection. exposure: 15 minutes at 10 degrees C after each session, three days a week for seven weeks evidence_span: {"source_cache": "artifacts/cold-research/31513450.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "f39d3b6bef4879805e7aab7b14df67921ac12765af5d4466836936039ad7a872", "start_char": 0, "end_char": 2195, "text_sha256": "f39d3b6bef4879805e7aab7b14df67921ac12765af5d4466836936039ad7a872"} [cold-p31513450] Cold water immersion attenuates anabolic signaling and skeletal muscle fiber hypertrophy, but not strength gain, following whole-body resistance training. (2019). https://pubmed.ncbi.nlm.nih.gov/31513450/ DOI: 10.1152/japplphysiol.00127.2019
Complete structured claim and evidenceSatellite cells expressing NCAM and Pax7 increased 24 to 48 hours after exercise with active recovery, and numbers were greater after active recovery than after immersion, while phosphorylation of p70S6 kinase at Thr421/Ser424 increased after exercise in both conditions but was greater after active recovery.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/cold-research/26174323.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "91eff53ecc4779637af3d6fd47a67892729e3a896fdc8738f69d1c7936b4787d", "start_char": 0, "end_char": 1595, "text_sha256": "91eff53ecc4779637af3d6fd47a67892729e3a896fdc8738f69d1c7936b4787d"}
- experimental_model
- Twelve weeks of strength training in 21 men with immersion or active recovery, plus a biopsy study in nine men
- exposure
- 10 minutes of cold water immersion after each training session, twice weekly for 12 weeks
- limitations
- A randomised training study with muscle biopsies. It measures long-term adaptation rather than acute recovery, which is why it can disagree with the soreness literature without contradicting it.
- nutrient_topic
- Cold water immersion research collection; topical membership is not evidence of a direct clinical effect, and a therapeutic exposure is not a dietary intake. · Cold water immersion
- organism
- Human
- plain_language
- The repair cells that build new muscle showed up in smaller numbers after the cold.
- primary_references
- [cold-p26174323] Post-exercise cold water immersion attenuates acute anabolic signalling and long-term adaptations in muscle to strength training. (2015). https://pubmed.ncbi.nlm.nih.gov/26174323/ DOI: 10.1113/jp270570
- tissue_or_cell_type
- Skeletal muscle
Cold water immersion: cold sensing, heat production, the catecholamine axis and what repeated exposure changes (2026-09-19) · lines 819–830
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Twelve weeks of strength training in 21 men with immersion or active recovery, plus a biopsy study in nine men · source_derived_draft · unverified_draft
### cold-cwi-satellite-cells Satellite cells expressing NCAM and Pax7 increased 24 to 48 hours after exercise with active recovery, and numbers were greater after active recovery than after immersion, while phosphorylation of p70S6 kinase at Thr421/Ser424 increased after exercise in both conditions but was greater after active recovery. Condition category: normal nutrient_topic: Cold water immersion research collection; topical membership is not evidence of a direct clinical effect, and a therapeutic exposure is not a dietary intake. plain_language: The repair cells that build new muscle showed up in smaller numbers after the cold. organism: Human tissue_or_cell_type: Skeletal muscle experimental_model: Twelve weeks of strength training in 21 men with immersion or active recovery, plus a biopsy study in nine men limitations: A randomised training study with muscle biopsies. It measures long-term adaptation rather than acute recovery, which is why it can disagree with the soreness literature without contradicting it. exposure: 10 minutes of cold water immersion after each training session, twice weekly for 12 weeks evidence_span: {"source_cache": "artifacts/cold-research/26174323.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "91eff53ecc4779637af3d6fd47a67892729e3a896fdc8738f69d1c7936b4787d", "start_char": 0, "end_char": 1595, "text_sha256": "91eff53ecc4779637af3d6fd47a67892729e3a896fdc8738f69d1c7936b4787d"} [cold-p26174323] Post-exercise cold water immersion attenuates acute anabolic signalling and long-term adaptations in muscle to strength training. (2015). https://pubmed.ncbi.nlm.nih.gov/26174323/ DOI: 10.1113/jp270570
Complete structured claim and evidenceEGCG reduced AKT Ser473 phosphorylation alongside proliferation in the tested cancer cells.
Experimental context and source evidence
- experimental_model
- MDA-MB-231 and A549 cells.
- limitations
- A pathway readout does not establish a unique causal target or human anticancer efficacy.
- nutrient_topic
- EGCG collection; comparator and shared-pathway records retain their actual intervention. · Epigallocatechin-3-gallate (EGCG)
- plain_language
- Downstream growth signaling changed in the cell experiments.
- primary_references
- Epigallocatechin gallate (EGCG), a major component of green tea, is a dual phosphoinositide-3-kinase/mTOR inhibitor. · 2011 · https://pubmed.ncbi.nlm.nih.gov/21300025/ · DOI 10.1016/j.bbrc.2011.02.010
EGCG: receptor signaling, metabolism, nutrient interactions and discovery questions (2026-09-18) · lines 228–234
AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · MDA-MB-231 and A549 cells. · source_derived_draft · unverified_draft
## egcg-akt Downstream growth signaling changed in the cell experiments. EGCG reduced AKT Ser473 phosphorylation alongside proliferation in the tested cancer cells. Model: MDA-MB-231 and A549 cells. Limitations: A pathway readout does not establish a unique causal target or human anticancer efficacy. Evidence access: primary abstract. Epigallocatechin gallate (EGCG), a major component of green tea, is a dual phosphoinositide-3-kinase/mTOR inhibitor. · 2011 · https://pubmed.ncbi.nlm.nih.gov/21300025/ · DOI 10.1016/j.bbrc.2011.02.010
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.